Catalent has expanded its Singapore facility, which recently received GMP approval from the Health Science Authority, to provide secondary packaging and labeling capabilities. The site is now fully approved for GMP across all its activities, including secondary packaging, label printing, storage, distribution, returns and destruction management. “Our Singapore facility is a strategic hub for Catalent’s Asia Pacific clinical supply network, with expertise in storage and distribution of clinica...